Navigation Links
Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
Date:3/1/2011

RICHMOND, Calif., March 1, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 10:15 am ET on Tuesday, March 8, 2011 at the Cowen and Company 31st Annual Health Care Conference which will be held in Boston.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification.  The most advanced ZFP Therapeutic® development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has a Phase 1/2 clinical trial and two ongoing Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS as well as a Phase 1 trial of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on Parkinson's disease, monogenic diseases, neuropathic pain and nerve regeneration.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developin
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
2. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
3. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
4. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
6. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
7. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
9. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
10. Sangamo Announces Closing of Common Stock Offering
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... WEST JORDAN, Utah , Aug. 29, 2014 /PRNewswire/ ... Imaging Solutions, has acquired Polaris Medical Imaging, a leader ... CT scanners. This strategic acquisition allows BC Technical to ... their capabilities, specifically within MR and CT modalities. ... lower cost service," said Mark Alvarez , president ...
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2China Orthopedic Instrument Industry Report, 2014-2017 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2
... Md., Nov. 4, 2010 The U.S. Food ... to treat chronic musculoskeletal pain, including discomfort from ... first used to treat major depressive disorder in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ...
... Calif., Nov. 4, 2010 ThermoGenesis Corp. (Nasdaq: ... and services that process and store adult stem cells, ... China and Hong Kong for its products used to ... at the point-of-care and in the laboratory. ...
Cached Medicine Technology:FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 2ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 3ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 4ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China 5
(Date:8/29/2014)... Today, Gen. Arthur T. Dean, Chairman and CEO ... the nation’s leading substance abuse prevention organization, issued the ... nominate Michael Botticelli as the Director of National Drug ... to nominate Michael Botticelli as our nation’s drug czar. ... important position at this time in our nation. Not ...
(Date:8/29/2014)... August 29, 2014 According to ... begin accepting applications next month for medical marijuana, ... into accepting marijuana as a legalized medicine. New ... will be permitted to operate in accordance with ... be best suited to handle legal cannabis. ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... “The Safety Chick” who profiled a handful of ... Earphones from Etymotic Research. This year, many schools ... and Etymotic, an innovator of hearing wellness solutions, ... Their ETY•Kids Safe-Listening Earphones, offered in yellow, pink ...
(Date:8/29/2014)... August 29, 2014 LiveOps, Inc., the ... solutions, today announced that LiveOps has been selected as ... (MDA) Show of Strength Telethon for the third year ... money and awareness to support MDA’s mission to help ... and sometimes fatal muscle disease. This year’s program includes ...
(Date:8/29/2014)... (August 29, 2014, 2 PM US Eastern Time)The ... to inject antibodies, commonly produced in animals, to ... ranging from safety to difficulties in developing, producing ... , New research led by Charles Shoemaker, Ph.D., ... Global Health at the Cummings School of Veterinary ...
Breaking Medicine News(10 mins):Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2
... DALLAS, Nov. 23 The Beryl Companies, the nation,s leading ... has earned recognition as one of the top outsourcing firms ... trade magazine. Beryl was ranked among the publication,s top 20 ... it to climb from twelfth place in 2007 to tenth ...
... ... for its QlikView Business Intelligence Software , ... Radnor, PA (PRWEB) November 23, 2009 -- ... was recognized with the Healthcare IT Innovation™ Award in the Best New Technology ...
... MIAMI, Nov. 23 Dr. Siegal,s Direct Nutritionals, LLC, ... operator of web site CookieDiet.com ( www.CookieDiet.com ), today ... ever-popular hunger-satisfying cookies are available on Samsclub.com, the web ... "We,re proud to welcome Samsclub.com as the latest of ...
... time, scientists have demonstrated that stem cells found in ... become specialized cell types, which suggests they may be ... conditions than scientists originally thought. Reporting in ... research teams of Anthony Atala, M.D., director of the ...
... New ... ... 2009 -- Moravia Worldwide, a leading globalization solution provider, announced today the appointment of ... he will lead the established business services team in these countries and have an ...
... ... the exclusive community of Cherry Hills Village, Denver, CO, by Absolute Auction December 3, 2009. ... Denver, Colo. (PRWEB) ... in Cherry Hills Village in Denver, Colo., and you are immediately and keenly aware that ...
Cached Medicine News:Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:Dr. Siegal's COOKIE DIET(R) Cookies Available at Samsclub.com 2Health News:New research shows versatility of amniotic fluid stem cells 2Health News:Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 2Health News:Barbara Fentress, Designer of the Denver International Airport and Convention Center, Offers Her Private Mansion at Absolute Auction 2
MW 96-W1 microplate washer with one wash line....
... is a compact and simple to ... micropumps enable the system both to ... types of microtiter well. MW-1200 holds ... rows of 8 wells or in ...
High-quality microplate washer with robot compatibility. It offers additional washing capacity, first-rate efficiency in high-throughput and research applications....
Wellwash 384 is an efficient, rapid and reliable washing process for high-throughput screening. It has been designed to optimize the washing process and ensure the best results. Available in 384 or 9...
Medicine Products: